Specimen SS-F-AST-358 // ASTRINGENCY · IFI-A
Catechin Profile Optimization V-PR-B
Camellia sinensis
Tea
Target Trait
4.02×
fold-change
EGCG:ECG:EC catechin molar ratio index
Technical Specifications
SKU
SS-F-AST-358
Genomic Edits
9
GC Content
46.9%
Construct Length
4,661 bp
Promoter System
Ubiquitin / T7
Expression System
Protoplast PEG-fusion
Host Strain
PEG-mediated
Receptor Target
Polyphenol-astringency axis
IFI Score
402
Pathway Edits
- ANR differential expression (anthocyanidin reductase) for epicatechin flux control
- LAR allelic balancing (leucoanthocyanidin reductase) for catechin:epicatechin ratio
- F3-5H overexpression (flavonoid 3',5'-hydroxylase) for gallated catechin precursor enrichment
- DFR allelic selection for 3',4'- vs 3',4',5'-dihydroxyl substrate preference
- FLS suppression (flavonol synthase) to redirect dihydroflavonol flux toward catechins
- Protoplast PEG-fusion transient and stable integration protocol
- Enhanced flux via 5'UTR synthetic leader sequence optimization
Key Interventions
IFI Subscale Profile
IFI Profile
Use Case
Flagship premium green tea analog ingredient, pharmaceutical-grade EGCG standardization, precision catechin ratio ingredient production. Enhanced variant for premium or research-grade applications requiring peak astringency fidelity.
License
$10049 · Tier V License
Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.
Already purchased?